St. Luke's University Hospital and Health Network
Bethlehem, Pennsylvania, 18015, United States
NCT Number: NCT02650245
The investigators specific aim is to evaluate the changes in breath ammonia in comparison to blood ammonia and other physiologic markers after a moderate oral protein challenge in healthy subjects and subjects with liver cirrhosis.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Bethlehem, Pennsylvania, 18015, United States
Ammonia is an important molecule relevant to numerous diseases, especially to the millions of patients with cirrhosis worldwide. Venous blood ammonia via limb phlebotomy, can at best roughly estimate whole body ammonia, but says little or nothing about intestinal production, and cannot "source" ammonia to any particular organ or body compartment. Unfortunately, there are no presently available better tests. Therefore, despite these acknowledged limitations, venous ammonia the "bronze standard" benchmark by which new metrics are assessed.
The present protocol attempts to address both concerns and build upon the investigators prior high protein experience. By using a standard moderate protein challenge, the investigators can evaluate the breath ammonia responsiveness in healthy subjects and those with cirrhosis. This protocol leverages the power of breath research to evaluate responses to oral challenges. This remains a key asset of breath research.
Since the protocol proposes a moderate protein challenge, the investigators can evaluate disease states with minimal or no risk. As with past high protein studies, lactulose (10gm) will still be added to provoke a hydrogen response.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 5 hours
Evaluating change in breath ammonia at hour 5 compared to baseline
St. Luke's Hospital and Health Network, Pennsylvania
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01842581
Brain Diseases, Brain Diseases, Metabolic
Phoenix, Arizona, United States
View Trial DetailsNCT01080144
Brain Diseases, Central Nervous System Diseases
Toulouse, Hôpital Rangueil, France
View Trial DetailsNCT00764049
Acute on Chronic Hepatic Failure, Acute-On-Chronic Liver Failure
Clichy, France
View Trial DetailsNCT01231828
Brain Diseases, Central Nervous System Diseases
Caen, France
View Trial Details